Menu

Experience

Rick Jantz

    • X4 Pharmaceuticals in its Exclusive License Agreement with Abbisko Therapeutics 


    • GENFIT SA in its Licensing and Collaboration Agreement with Terns Pharmaceuticals 


    • Vir Biotechnology - $143 Million IPO 


    • Arlo to Partner with Verisure 


    • Reata Pharmaceuticals – $505 Million Follow-On Offering 


    • Synthorx to Sell to Sanofi for $2.5 Billion 


    • Vivid Cortex Sells to SolarWinds  


    • DocuSign to Acquire AI Technology Provider Seal Software 


    • Genesis MedTech Acquires Drug Device Asset From TriReme Medical 


    • Olive Closes $225 Million Financing, Acquires Verata Health 


    • ShipMonk Raises $290 Million From Summit Partners 


    • Celularity to Go Public Through SPAC Merger 


    • Uber to Acquire Drizly for $1.1 Billion 


    • Datalogue Sells to Nike 


    • Brandwatch Agrees to Sell to Cision for $450 Million 


    • IonQ Agrees to SPAC Merger With dMY Technology Group III 


    • Timber Technologies Sells to Datadog 


    • Meredith Agrees to Sell TV Broadcast Group to Gray Television for $2.8 Billion 


    • Vertebrae Sells to Snap 


    • Kredivo Agrees to SPAC Merger With VPC Impact Acquisition Holdings II 


    • Gusto Agrees to Acquire Symmetry 


    • Snyk Hits $8.5 Billion Valuation With Series F Round 


    • Meredith Agrees to Sell National Media Group to IAC’s Dotdash 


    • Lulu’s – $92 Million IPO 


    • Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II 


    • Asymchem Laboratories – HK$7.15 Billion IPO 


    • Cybersecurity Startup Snyk Acquires Cloud Security and Compliance Company Fugue 


    • Carpe Data Receives Strategic Growth Investment From Thomas H. Lee Partners